Jonathan E Lim's Net Worth
$176 Million
Who is Jonathan E Lim?
Jonathan E Lim has an estimated net worth of $176 Million. This is based on reported shares across multiple companies, which include Erasca, Inc., HALOZYME THERAPEUTICS INC, and Ignyta, Inc..
SEC CIK
Jonathan E Lim's CIK is 0001283290
Past Insider Trading and Trends
2007 was Jonathan E Lim's most active year for acquiring shares with 10 total transactions. Jonathan E Lim's most active month to acquire stocks was the month of January. 2007 was Jonathan E Lim's most active year for disposing of shares, totalling 215 transactions. Jonathan E Lim's most active month to dispose stocks was the month of July. 2023 saw Jonathan E Lim paying a total of $4,512,598.95 for 3,760,000 shares, this is the most they've acquired in one year. In 2018 Jonathan E Lim cashed out on 4,149,661 shares for a total of $95,300,847.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Erasca, Inc. (ERAS) Snapshot price: $1.7785
Chairman & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
| +4.03% | 1M |
$1.71 | $1,696,178.95 | 25.8M |
Dec 5 - Dec 6
| |||
Form 4
| +5.42% | 1M |
$2.03 | $2,026,000.00 | 19.46M |
Oct 5
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +0.55% | 100K |
$2.75 | $275,000.00 | 18.4M |
Jun 8
| |||
Form 4
| +0.55% | 100K |
$2.84 | $284,000.00 | 18.3M |
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +0.30% | 60K |
$3.86 | $231,420.00 | 20.26M |
Jan 10
| |||
Form 4
| +0.20% | 40K |
$4.99 | $199,600.00 | 20.2M |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +49.24% | 10.58M |
—
|
—
| 32.06M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HALOZYME THERAPEUTICS INC (HALO) Snapshot price: $35.48
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +4.41% | 30K |
$0.39 | $11,700.00 | 710K |
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
| -26.88% | -250.00K |
$6.06 | -$1,515,000.00 | 680K |
Mar 20
| |||
Form 4
| +32.86% | 230K |
$0.39 | $89,700.00 | 930K |
Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
$4.32 | -$156,996.24 | 700K |
Scheduled
|
Nov 30
| ||
Form 4
|
—
|
0
|
$4.71 | -$216,099.90 | 700K |
Scheduled
|
Oct 31
| ||
Form 4
| +3.96% | 26.69K |
$0.45 | $11,999.82 | 700K |
Oct 16
| |||
Form 4
|
—
|
0
|
$4.59 | -$209,773.76 | 673.31K |
Scheduled
|
Sep 28
| ||
Form 4
| -1.87% | -12.80K |
$8.82 | -$112,839.84 | 673.31K |
Scheduled
|
Aug 31
| ||
Form 4
| +1.90% | 12.8K |
$4.48 | -$94,757.65 | 686.11K |
Scheduled
|
Aug 31
| ||
Form 4
|
—
|
0
|
$4.30 | -$156,132.60 | 673.31K |
Scheduled
|
Jul 31
| ||
Form 4
| -1.20% | -8.20K |
$9.59 | -$78,594.40 | 673.31K |
Scheduled
|
Jun 29
| ||
Form 4
| +1.22% | 8.2K |
$4.91 | -$148,625.99 | 681.51K |
Scheduled
|
Jun 29
| ||
Form 4
| +16.69% | 96.31K |
$0.39 | $37,562.07 | 673.31K |
Jun 25
| |||
Form 4
| -1.01% | -5.90K |
$10.59 | -$62,469.37 | 577K |
Scheduled
|
May 31
| ||
Form 4
| -1.12% | -6.60K |
$5.37 | -$192,726.66 | 582.9K |
Scheduled
|
May 31
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
| +20.43% | 100K |
$0.39 | $39,000.00 | 589.5K |
Mar 24
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +1.03% | 5K |
$1.61 | $8,050.00 | 489.5K |
Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ignyta, Inc. No price found
President, CEO & Director
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.53M |
$27.00 | -$95,300,847.00 |
0
|
Feb 8
| |||
Form 4
| -9.57% | -19.01K |
$26.70 | -$507,460.20 | 179.66K |
Dec 26
| |||
Form 4/A
| +52.43% | 68.33K |
—
|
—
| 198.67K |
Dec 22
| |||
Form 4
| +52.43% | 68.33K |
—
|
—
| 198.67K |
Dec 22
| |||
Form 4
| +5.63% | 6.95K |
$0.60 | $4,167.00 | 130.33K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +27.20% | 26.39K |
$0.60 | $15,832.80 | 123.39K |
Apr 11
| |||
Form 4
| +0.75% | 24.85K |
$5.51 | $136,879.85 | 3.35M |
Mar 17
| |||
Form 4
| +288.00% | 72K |
—
|
—
| 97K |
Jan 7
| |||
Form 4
| +0.26% | 8.48K |
$12.90 | $109,402.22 | 3.33M |
Aug 19 - Aug 20
| |||
Form 4
| +400.00% | 20K |
$9.01 | $180,200.00 | 25K |
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
∞
| 5K |
$7.60 | $37,997.00 | 5K |
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Boundless Bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +2,048.57% | 525.27K |
—
|
—
| 550.91K |
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||